OptiSkin Medical is a clinical research site located in New York, New York, United States 10128.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
OptiSkin Medical has participated in 11 clinical trials with 6 currently active.
Therapeutic areas: Eczema, Atopic Dermatitis, Plaque Psoriasis.
Sponsors: OptiSkin Medical, Celldex Therapeutics, Eli Lilly and Company.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
OptiSkin Medical has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
OptiSkin Medical has 11 clinical trials on record, with 6 currently active. Their work covers Eczema, Atopic Dermatitis, Plaque Psoriasis.
Yes — OptiSkin Medical holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.